The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: A meta-analysis

Tohoku Journal of Experimental Medicine

Volumn 220, Issue 4, 2010, Pages 291-297

  Lu, Weixin ^a   Feng, Bo ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Diabetes complications; Gene polymorphism; Meta analysis; Receptor for advanced glycation end products; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALANINE;

ARTICLE; CAUCASIAN; ETHNICITY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; PROPHYLAXIS; SENSITIVITY ANALYSIS; VASCULAR DISEASE;

ALLELES; BLOOD VESSELS; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 77951250397     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.220.291     Document Type: Article

References (28)

1. Brett, J., Schmidt, A.M., Yan, S.D., Zou, Y.S., Weidman, E., Pinsky, D., Nowygrod, R., Neeper, M., Przysiecki, C., Shaw, A., Migheli, A. & Stern, D. (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol., 143, 1699-1712.
2. Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K.T. & Nawroth, P.P. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med., 198, 1507-1515.
3. Chowdhury, T.A., Dyer, P.H., Kumar, S., Barnett, A.H. & Bain, S.C. (1999) Genetic determinants of diabetic nephropathy. Clin. Sci. (Lond), 96, 221-230.
4. Cipollone, F., Iezzi, A., Fazia, M., Zucchelli, M., Pini, B., Cuccurullo, C., De Cesare, D., De Blasis, G., Muraro, R., Bei, R., Chiarelli, F., Schmidt, A.M., Cuccurullo, F. & Mezzetti, A. (2003) The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation, 108, 1070-1077.
5. dos Santos, K.G., Canani, L.H., Gross, J.L., Tschiedel, B., Pires Souto, K.E. & Roisenberg, I. (2005) The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in AfricanBrazilians with type 2 diabetes. Mol. Genet. Metab., 85, 149-156.
6. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
7. Globocnik Petrovic, M., Steblovnik, K., Peterlin, B. & Petrovic, D. (2003) The 429 T/C and 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin. Monatsbl. Augenheilkd., 220, 873-876.
8. Hudson, B.I., Stickland, M.H., Futers, T.S. & Grant, P.J. (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes, 50, 1505-1511.
9. JiXiong, X., Bilin, X., MingGong, Y. & ShuQin, L. (2003) -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care, 26, 2696-2697.
10. Kalea, A.Z., Schmidt, A.M. & Hudson, B.I. (2009) RAGE: a novel biological and genetic marker for vascular disease. Clin. Sci. (Lond), 116, 621-637.
11. Kankova, K., Benes, P. & Kuchrickova, S. (2010) Functional analysis of the common haplotype in the receptor for advanced glycation end-products gene previously identified as a susceptibility factor for diabetic nephropathy. Exp. Clin. Endocrinol. Diabetes, 118, 93-95.
12. Kankova, K., Stejskalova, A., Hertlova, M. & Znojil, V. (2005) Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant., 20, 1093-1102.
13. Kirbis, J., Milutinović, A., Steblovnik, K., Teran, N., Terzić, R. & Zorc, M. (2004) The -429T/C and -374T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll. Antropol., 28, 611-616.
14. Lau, J., Ioannidis, J.P. & Schmid, C.H. (1997) Quantitative synthesis in systematic reviews. Ann. Intern. Med., 127, 820-826.
15. Lindholm, E., Bakhtadze, E., Cilio, C., Agardh, E., Groop, L. & Agardh, C.D. (2008) Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PloS ONE, 3, e2546.
16. Lindholm, E., Bakhtadze, E., Sjogren, M., Cilio, C.M., Agardh, E., Groop, L. & Agardh, C.D. (2006) The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia, 49, 2745-2755.
17. Lu, L., Jin Pu, L., Chen, Q.J., Wang, L., Peng, W., Yan, X., Zhang, Q., Yan Zhang, R., Gong, P.H., Qiu, J.P. & Shen, W.F. (2008) Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clin. Chim. Acta, 396, 33-37.
18. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C., Elliston, K., Stern, D. & Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem., 267, 14998-15004.
19. Peng, W.H., Lu, L., Wang, L.J., Yan, X.X., Chen, Q.J., Zhang, Q., Zhang, R.Y. & Shen, W.F. (2009) RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Arch. Med. Res., 40, 393-398.
20. Ramprasad, S., Radha, V., Mathias, R.A., Majumder, P.P., Rao, M.R. & Rema, M. (2007) Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye (Lond), 21, 395-401.
21. Soulis, T., Thallas, V., Youssef, S., Gilbert, R.E., Mcwilliam, B.G., Murray-Mcintosh, R.P. & Cooper, M.E. (1997) Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia, 40, 619-628.
22. Sugaya, K., Fukagawa, T., Matsumoto, K., Mita, K., Takahashi, E., Ando, A., Inoko, H. & Ikemura, T. (1994) Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counter-part of mouse mammary tumor gene int-3. Genomics, 23, 408-419.
23. Vlassara, H. & Palace, M.R. (2002) Diabetes and advanced glycation endproducts. J. Intern. Med., 251, 87-101.
24. Warpeha, K.M. & Chakravarthy, U. (2003) Molecular genetics of microvascular disease in diabetic retinopathy. Eye (Lond), 17, 305-311.
25. Weir, B. (1996) Genetic data analysis II: Methods for discrete population genetic data. Sinauer Associates, Sunderland MA, USA.
26. Winkelmann, B.R. & Hager, J. (2000) Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics, 1, 73-94.
27. Xu, J., Turner, A., Little, J., Bleecker, E.R. & Meyers, D.A. (2002) Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum. Genet., 111, 573-574.
28. Zee, R.Y., Romero, J.R., Gould, J.L., Ricupero, D.A. & Ridker, P.M. (2006) Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke, 37, 1686-1690.